HL-50

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHL-50
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionantioxidantNuclear factor erythroid 2-related factor 2 stimulantsNeuroprotectants
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKorea Institute Of Science And Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorea Institute Of Science And Technology
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A